Webinar: Human-like pattern of expression of Fcγ receptors in humanized mouse model to advance antibody modeling, September 22, 2026

genOway presentation

Event
-
September 22, 2026

genOway’s joint webinar with VIB/Ghent University

‍

Tuesday, September 22, 2026 - 5:30 pm CET / 11:30 am EST / 8:30 am PST

Presenter: Karel Van Damme PhD, VIB-UGent Center for Inflammation Research, Ghent University

Title: "Human-like pattern of expression of Fcγ receptors in humanized mouse model to advance antibody modeling"

Presentation highlights:

  • Discover how Fcγ receptor biology differs across species - Explore key differences between human, macaque, and mouse immune cells and what they mean for antibody research
  • See how humanized mouse models can improve preclinical studies - Mice expressing human Fcγ receptors and FcRn reproduced human Fcγ receptor functions across different experimental models

Register here: https://events.teams.microsoft.com/event/e687517a-c095-4995-8c28-bbff51e86c7e@3728edc1-c7e2-4d3c-b801-37740853e675?source=copyLinkOneEventsShareDialog

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
Festival of Biologics, Basel Switzerland, October 13-15, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Lunch & Learn, October 7th, San Diego Biomedical Research Institute: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Oct 2026
Read on
BioJapan, Yokohama, October 7-9, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Lunch & Learn, October 6th, Salk Institute for Biological Studies: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe